Monday, September 8, 2014
Ignyta Names CSO
San Diego-based biotechnology developer Ignyta said this morning that it has named Robert Wild, Ph.D., as the company's new Chief Scientific Officer and Senior Vice President, Research. Wild was most recently Chief Scientific Officer, Oncology Research, Drug Discovery at Eli Lilly & Company, and also has served at OSI Pharmaceuticals and Bristol-Myers Squibb. Ignyta is focused on cancer treatments.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More